Extera Partners Adds Steven Bernitz as a General Partner

Extera Facilitates National Distribution Agreements (Hebrew/PDF)

Extera Facilitates Partnership Deal Between Exalenz Biosciences and Metabolic Solutions Inc (Israeli press/Hebrew/PDF)

Exalenz builds US sales infrastructure with Extera’s Support (Hebrew/PDF)

Lothar Koob (GP) In The Press: "FDA Clears Nexstim's Navigated Brain Stimulation"

Lothar Koob Joins EDGE Medical Devices Board of Directors

Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation

Extera is supporting strategy and commercialization efforts of a leading Israeli life science company (Israeli press/Hebrew/PDF)

Extera Partners to moderate a panel at the MIT Sloan BioInnovations Conference in Cambridge Massachusetts

Dr. Robert Parnell Joins Extera Partners to Expand Its Diagnostics Advisory Capabilities

Innovations in Breast Imaging: (Highlighting Extera's work with Karmanos Cancer Institute) (PDF)

Novelos Therapeutics Inc. (OTCBB: NVLT), obtains FDA Fast Track Designation (PDF)

Life Science Development is featured in the Globes, the leading business news paper in Israel (PDF)

Alchemia Limited ((ASX: ACL), is named Queensland's "Smartest" company (PDF)

Genetic Engineering & Biotechnology News: "How Biotech Unions Could Save Companies and Revitalize Pipelines"(PDF)
By Joseph Baron, Extera Partners

Pharma Voice: "REFORM, CONSOLIDATION AND GOOD CITIZENRY" (PDF)
Interview with Joseph Baron, Extera Partners